VENTO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 1.035
EU - Europa 746
AS - Asia 620
SA - Sud America 218
AF - Africa 13
OC - Oceania 1
Totale 2.633
Nazione #
US - Stati Uniti d'America 1.010
SG - Singapore 275
BR - Brasile 187
IE - Irlanda 180
SE - Svezia 171
CN - Cina 137
IT - Italia 118
DE - Germania 75
HK - Hong Kong 74
PL - Polonia 51
VN - Vietnam 39
IN - India 29
FI - Finlandia 28
FR - Francia 28
GB - Regno Unito 25
RU - Federazione Russa 16
JP - Giappone 15
AR - Argentina 11
CA - Canada 11
BE - Belgio 9
LT - Lituania 9
ES - Italia 8
IQ - Iraq 7
ZA - Sudafrica 7
AT - Austria 6
BD - Bangladesh 6
TR - Turchia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
MX - Messico 5
NL - Olanda 5
PE - Perù 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
UA - Ucraina 4
AZ - Azerbaigian 3
ID - Indonesia 3
IR - Iran 3
PA - Panama 3
BY - Bielorussia 2
CH - Svizzera 2
CL - Cile 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
MA - Marocco 2
PK - Pakistan 2
SA - Arabia Saudita 2
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CO - Colombia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
TW - Taiwan 1
Totale 2.633
Città #
Chandler 205
Ashburn 196
Dublin 178
Singapore 136
Nyköping 120
Hong Kong 74
Dallas 73
Beijing 53
Messina 48
Warsaw 48
The Dalles 38
Munich 34
Princeton 33
Los Angeles 31
Medford 24
Bremen 23
Des Moines 20
Ho Chi Minh City 16
São Paulo 15
Helsinki 14
Turku 14
Dearborn 13
Ann Arbor 12
Hyderabad 12
Buffalo 11
Rome 11
Frankfurt am Main 10
Jinan 10
Kameido 10
Redondo Beach 10
Brussels 9
Jacksonville 9
Mumbai 9
Hanoi 8
Moscow 8
Nanjing 8
Boardman 7
New York 7
Seattle 7
Tianjin 7
Dong Ket 6
Hangzhou 6
Nuremberg 6
West Jordan 6
Atlanta 5
Bexley 5
Stockholm 5
Tashkent 5
Tokyo 5
Blumenau 4
Brooklyn 4
Curitiba 4
Goiânia 4
Nanchang 4
Ottawa 4
Porto Alegre 4
Quito 4
Redwood City 4
Santa Clara 4
Waverly Hall 4
Amsterdam 3
Baku 3
Campinas 3
Catania 3
Chicago 3
Denver 3
Florence 3
Jakarta 3
Johannesburg 3
Lima 3
Manaus 3
Manchester 3
Milan 3
Mislata 3
Oklahoma City 3
Olomouc 3
Pune 3
Salvador 3
San Francisco 3
Santa Domenica 3
São Bernardo do Campo 3
Temple 3
Toronto 3
Torregrotta 3
Vienna 3
Wroclaw 3
Alvorada 2
Ankara 2
Augusta 2
Baghdad 2
Bauru 2
Belo Horizonte 2
Bismarck 2
Carney 2
Chengdu 2
Columbus 2
Council Bluffs 2
Dhaka 2
Dubai 2
Fiumefreddo Di Sicilia 2
Totale 1.770
Nome #
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 141
PRRT Retreatments: Renal Function Evaluation 138
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 129
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 128
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 121
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 117
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 116
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 115
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 112
Dual Time-Point FET-PET/CT in Glioma Patients: a Single-Centre Preliminary Experience 111
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 107
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 106
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 106
PRRT retreatments: renal function evaluation 104
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 97
Renal Function Evaluation in PRRT Retreatments 97
Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience 89
Artifcial intelligence applications in SSTR targeted PET/CT images: prediction of response assessment in GEP-NETs undergoing PRRT with [177Lu]DOTATOC 87
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 84
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 80
The utility of dual time-point FET-PET/CT in recurrence assessment of glioma patients 80
Artificial intelligence applications in 68Ga-DOTA PETICT images: Prediction of response assessment in GEP-NETs undergoing PRRT with 177Lu-DOTATOC 73
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 62
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 59
Response prediction to PRRT in progressing and metastatic GEP-NET undergoing restaging 68Ga-DOTA PETICT: A preliminary multicenter radiomics study 50
Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals 47
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature 46
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 41
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study 36
null 23
Totale 2.702
Categoria #
all - tutte 11.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 12 12 13 18 11 9 9
2021/2022228 1 13 2 10 20 1 21 21 2 25 20 92
2022/2023626 55 90 27 59 46 58 8 46 217 5 12 3
2023/2024146 13 13 7 8 18 22 9 10 0 13 13 20
2024/2025765 9 22 17 30 50 25 54 118 169 68 122 81
2025/2026693 174 118 102 103 171 25 0 0 0 0 0 0
Totale 2.702